PMID- 31894100
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230711
IS  - 1535-9484 (Electronic)
IS  - 1535-9476 (Print)
IS  - 1535-9476 (Linking)
VI  - 19
IP  - 1
DP  - 2020 Jan
TI  - Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in 
      sorafenib-resistant hepatocellular carcinoma cells revealed by array-based 
      pathway profiling.
PG  - 223
LID - S1535-9476(20)30017-7 [pii]
LID - 10.1074/mcp.AAC119.001903 [doi]
FAU - Masuda, Mari
AU  - Masuda M
FAU - Chen, Wei-Yu
AU  - Chen WY
FAU - Miyanaga, Akihiko
AU  - Miyanaga A
FAU - Nakamura, Yuka
AU  - Nakamura Y
FAU - Kawasaki, Kumiko
AU  - Kawasaki K
FAU - Sakuma, Tomohiro
AU  - Sakuma T
FAU - Ono, Masaya
AU  - Ono M
FAU - Chen, Chi-Long
AU  - Chen CL
FAU - Honda, Kazufumi
AU  - Honda K
FAU - Yamada, Tesshi
AU  - Yamada T
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Mol Cell Proteomics
JT  - Molecular & cellular proteomics : MCP
JID - 101125647
SB  - IM
EFR - Mol Cell Proteomics. 2014 Jun;13(6):1429-38. PMID: 24643969
PMC - PMC6944242
EDAT- 2020/01/03 06:00
MHDA- 2020/01/03 06:01
PMCR- 2020/01/01
CRDT- 2020/01/03 06:00
PHST- 2020/01/03 06:00 [entrez]
PHST- 2020/01/03 06:00 [pubmed]
PHST- 2020/01/03 06:01 [medline]
PHST- 2020/01/01 00:00 [pmc-release]
AID - S1535-9476(20)30017-7 [pii]
AID - AAC119.001903 [pii]
AID - 10.1074/mcp.AAC119.001903 [doi]
PST - ppublish
SO  - Mol Cell Proteomics. 2020 Jan;19(1):223. doi: 10.1074/mcp.AAC119.001903.